Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against diabetes, hypertension & more.

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

Can we rely on these weight loss drugs to fight obesity? Are they the ultimate answer to the growing obesity pandemic? Or ...

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...